BCWM
WST icon

Bartlett & Co Wealth Management’s West Pharmaceutical WST Stock Holding History

Bartlett & Co Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21K Buy
14
+2
+17% +$498 ﹤0.01% 1039
2025
Q4 		$3.3K Hold
12
– – ﹤0.01% 1071
2025
Q3 		$3.15K Buy
12
+11
+1,100% +$2.67K ﹤0.01% 1056
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 1197
2024
Q2 		– Sell
-1
Closed -$396 – 1174
2024
Q1 		$396 Buy
+1
New +$370 ﹤0.01% 1092
2022
Q4 		– Sell
-7
Closed -$1.72K – 1195
2022
Q3 		$1.72K Sell
7
-9
-56% -$2.74K ﹤0.01% 1063
2022
Q2 		$4.84K Buy
+16
New +$5.21K ﹤0.01% 1022

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return